MyCural Welcomes their new Board Members Nina Herne PhD MBA and Per Källblad.
Nina Herne will take the role as the new Chair of the Board. Her long experience within drug development and business will contribute to MyCural strategies and future success.
Per Källblad has deep knowledge and understanding of development of small molecules as well as from entrepreneurship which will be key assets going forward for the Company.
